Navigation Links
Codexis to Present at the Pacific Crest and Jefferies Conferences
Date:2/1/2012

REDWOOD CITY, Calif., Feb. 1, 2012 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS), a leading producer of enzymes to enable affordable and abundant sugar for the production of fuels and chemicals, today announced that the company will be participating in the following upcoming investor conferences:Pacific Crest Emerging Technology SummitDate:

Wednesday, February 15, 2012Time:

10:00 a.m. PT (Panel: The Rise of Cellulosic Technologies) 

11:30 a.m. PT (Company presentation)Location:

San Francisco, CASpeaker:

Alan Shaw, Ph.D., President and Chief Executive Officer 

  

 Jefferies 2012 Global Clean Technology ConferenceDate:

Thursday, February 23, 2012 (Company presentation)Time:

1:45 p.m. ETLocation:

New York, NYSpeaker:

Joseph Sarret, M.D., Senior Vice President and Chief Business OfficerA webcast and replay of the company presentations will be available in the Investor section of www.codexis.com. A webcast for the panel discussion is not being provided at the conference.

Codexis is an industrial biotechnology company developing high value sustainable chemicals, clean fuels, cost effective pharmaceutical processes and renewable bioindustrial ingredients to make industry more efficient, productive and profitable.  Partners and customers include global leaders such as Shell, Merck and Pfizer.  For more information, see www.codexis.com.

Contacts: 
Media:  Lyn Christenson, Media@codexis.com, 650.421.8144
Investors:  Jay Sarwar, IR@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Codexis Names Wes Bolsen VP and Chief Marketing Officer
2. Shell Transfers Its Codexis Shares to Raizen
3. Codexis Reports First Quarter 2011 Results
4. Former Senator Byron Dorgan Elected to Codexis Board
5. Codexis Reports Fourth Quarter and Full Year 2010 Results
6. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
7. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
8. Codexis R&D Productivity Panels Also Used By Roche
9. Codexis Names Lori Giver VP Systems Biology
10. Codexis, Teva in Licensing Agreement Final
11. Codexis Names Vice President, Intellectual Property
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... (PRWEB) , ... January 12, 2017 , ... ... to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months ... a new drug combination that has stabilized Rosendahl’s disease and increased both the ...
(Date:1/12/2017)... MERIDEN, Conn. , Jan. 12, 2017 /PRNewswire/ ... development company and maker of Flublok Influenza ... based Zika vaccine candidate had good safety results ... virus in preclinical studies. The product is expected ... next few months.  In addition, the Institute of ...
(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock ... Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated to ... 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... journal Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib ... a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated patients ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
(Date:12/7/2016)... 7, 2016   Veridium , a leader ... of new CEO James Stickland . Stickland, ... of experience, has served in senior executive roles ... specialized in expanding a pipeline of venture capital ... most recently served as managing director of U.K.-based ...
Breaking Biology News(10 mins):